Boston Family Office’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$354K	Buy	796 +345	+76%	+$153K	0.02%	227
2025 Q1	$219K	Sell	451 -100	-18%	-$48.6K	0.02%	267
2024 Q4	$222K	Sell	551 -15	-3%	-$6.04K	0.02%	261
2024 Q3	$263K	Buy	+566	New	+$263K	0.02%	244